Spotlight on daclizumab: its potential in the treatment of multiple sclerosis.

Degener Neurol Neuromuscul Dis · 2016 · PMC6053094 · PMID 30050372

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

30 – 33 , 59 All 5 studies showed prominent and highly significant reductions in the number of new and total contrast-enhancing lesions (CEL) on brain MRI, reflecting the profound anti-inflammatory effect of daclizumab.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.